Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oberweis Emerging Growth Fund (OBEGX)

Net Asset Value
1 Day
Overall Morningstar Rating
World stock
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize capital appreciation. The fund invests, under normal circumstances, at least 80% of its net assets in the securities of relatively small companies, which, at the time of investment, have a market capitalization of less than or equal to $1.5 billion or are within the range of companies represented in the MSCI ACWI Small-Cap Index, whichever is greater and meet the Oberweis Aperture investment criteria. It may invest without limit in U.S. and non-U.S. companies. The fund may invest in equity-linked certificates issued and/or guaranteed by counterparties rated A or better by Moody's or S&P Corporation.


1 month+2.42% 3 years+17.24%
3 months+6.73% 5 years+9.29%
1 year+7.07% Since inception+8.63%
Data through --

Peer Comparisonvs. World stock

Performance 5-yr return+9.29%+7.37%
Expense ratio1.49%1.37%
Risk 5 year sharpe ratio0.560.64
Net assets$63.9M$1.2B
Average market cap$1.9B$42.2B
Average P/E29.018.5
Portfolio turnover95%95%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOberweis
Fund manager & tenureJames Oberweis / 14 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00


U.S. stock49.32%
International stock40.95%
Fixed income9.18%
Top 5 Sectors
Portfolio weighting
Hardware 28.86%
Industrial materials 12.12%
Business service 10.75%
Healthcare 10.70%
Consumer service 9.01%
Top 10 Holdings
Portfolio weighting
DPLO Diplomat Pharmacy Inc3.91%
SKX Skechers USA Inc2.56%
RUBI Rubicon Project Inc2.31%
SNCR Synchronoss Technologies Inc2.24%
THRM Gentherm Inc2.14%
-- 2.11%
ANIP ANI Pharmaceuticals Inc2.07%
-- 2.06%
INFN Infinera Corp2.03%
MDXG MiMedx Group Inc1.99%